GADD45A and Hepatic fibrosis: The increased expressions of CDKN1A and GADD45 in HSCs are associated with inhibited HSCs activation and ameliorated liver fibrosis in rats treated with PPARγ agonist or histone deacetylase inhibitor 62, 63.